Načítá se...
Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation
BACKGROUND & AIMS: Outcomes with anticoagulation are understudied in advanced liver disease. We investigated effects of anticoagulation (AC) with warfarin and DOACs on all-cause mortality and hepatic decompensation as well as ischemic stroke, major adverse cardiovascular events, splanchnic throm...
Uloženo v:
| Vydáno v: | Hepatology |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541418/ https://ncbi.nlm.nih.gov/pubmed/32267547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31264 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|